Mechanical Coring to Achieve Directional Skin Tightening

Description

The objective of this clinical study is to evaluate the safety and efficacy of mechanical coring for directional skin tightening. This study is a prospective, up to 3 center, multiple skin treatment area study of the safety and efficacy of mechanical coring with directional closure to achieve directional skin tightening.

Conditions

Skin Tightening, Healthy Volunteers

Study Overview

Study Details

Study overview

The objective of this clinical study is to evaluate the safety and efficacy of mechanical coring for directional skin tightening. This study is a prospective, up to 3 center, multiple skin treatment area study of the safety and efficacy of mechanical coring with directional closure to achieve directional skin tightening.

Pilot Study for the Clinical Evaluation of Mechanical Coring to Achieve Directional Skin Tightening

Mechanical Coring to Achieve Directional Skin Tightening

Condition
Skin Tightening
Intervention / Treatment

-

Contacts and Locations

Los Altos

Berman Skin Institute, Los Altos, California, United States, 94022

San Jose

Le's Aesthetics, San Jose, California, United States, 95112

Chicago

DeNova Research, Chicago, Illinois, United States, 60611

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Healthy, male or female subjects between 30 and 70 years of age.
  • 2. Able to read, understand, and voluntarily provide written Informed Consent.
  • 3. Able and willing to comply with the treatment/follow-up schedule and requirements.
  • 4. Women of childbearing age are required to be using a reliable method of birth control at least 3 months prior to study enrollment and for the duration of the study and have a negative Urine Pregnancy test at baseline.
  • 5. Subjects may have any Fitzpatrick skin type, however, no more than 35% of subjects may have Fitzpatrick skin type V or VI.
  • 1. Previous aesthetic (device and/or surgical) skin treatment in the treated areas (under arms and/or behind the ear) in the previous 6 months.
  • 2. Fat, collagen, silicone, tattoos, body jewelry, that cannot be removed for the duration of treatment, and tegaderm/glue application or any other synthetic material in the treatment area.
  • 3. History of keloid formation
  • 4. Active smoker or having quit smoking in the last 3 months.
  • 5. Active, chronic, or recurrent infection
  • 6. Compromised immune and/or healing system (e.g. diabetes)
  • 7. Hypersensitivity/allergy to analgesic agents, Betadine, tumescent, Benzoin Tincture, Tegaderm or tensioning tape that will be used in the study.
  • 8. Co-morbid condition that could limit the ability to participate in the study or to comply with follow-up requirements.
  • 9. Pregnant or breastfeeding
  • 10. Any indication that may cause excessive bleeding, e.g., anticoagulants.
  • 11. Carcinoma, melanoma, or any other cancerous condition in the last 6 months.
  • 12. Allergy to adrenaline, epinephrine, or Tranexamic acid (TXA).
  • 13. Currently or in the last 1-month part of another clinical study of an investigational drug and/or experimental medical device
  • 14. Any issue that, at the discretion of the investigator would contra-indicate the subject's participation.

Ages Eligible for Study

30 Years to 70 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Venus Concept,

Matthew Gronski, PhD, STUDY_DIRECTOR, Venus Concept

Study Record Dates

2025-08-31